Pharming Group N.V.
PHGUF
$1.30
$0.1412.07%
OTC PK
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 93.22M | 92.67M | 74.09M | 55.59M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 93.22M | 92.67M | 74.09M | 55.59M | |
| Cost of Revenue | 8.97M | 12.21M | 7.98M | 8.39M | |
| Gross Profit | 84.25M | 80.46M | 66.11M | 47.20M | |
| SG&A Expenses | 57.25M | 46.56M | 48.55M | 45.34M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -1.85M | -143.00K | -912.00K | -345.00K | |
| Total Operating Expenses | 90.17M | 80.94M | 77.21M | 71.90M | |
| Operating Income | 3.05M | 11.73M | -3.12M | -16.31M | |
| Income Before Tax | 7.08M | 6.68M | -60.00K | -16.62M | |
| Income Tax Expenses | 2.53M | 3.82M | 1.16M | -4.18M | |
| Earnings from Continuing Operations | 4.55M | 2.86M | -1.22M | -12.45M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 144.00K | -- | -- | -- | |
| Net Income | 4.69M | 2.86M | -1.22M | -12.45M | |
| EBIT | 3.05M | 11.73M | -3.12M | -16.31M | |
| EBITDA | 4.28M | 19.43M | -1.17M | -10.39M | |
| EPS Basic | 0.01 | 0.00 | 0.00 | -0.02 | |
| Normalized Basic EPS | 0.00 | 0.01 | 0.00 | -- | |
| EPS Diluted | 0.01 | 0.00 | 0.00 | -0.02 | |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.00 | -- | |
| Average Basic Shares Outstanding | 686.44M | 740.00M | 688.98M | 655.16M | |
| Average Diluted Shares Outstanding | 686.44M | 740.00M | 688.98M | 655.16M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |